DrugCite
Search

PREVISCAN FLUINDIONE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Previscan Fluindione Adverse Events Reported to the FDA Over Time

How are Previscan Fluindione adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Previscan Fluindione, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Previscan Fluindione is flagged as the suspect drug causing the adverse event.

Most Common Previscan Fluindione Adverse Events Reported to the FDA

What are the most common Previscan Fluindione adverse events reported to the FDA?

International Normalised Ratio Incr...
159 (7.51%)
Drug Interaction
119 (5.62%)
Anaemia
42 (1.98%)
Fall
38 (1.79%)
Haematoma
38 (1.79%)
Overdose
38 (1.79%)
Renal Failure
29 (1.37%)
Subdural Haematoma
18 (.85%)
Haemoglobin Decreased
17 (.8%)
Renal Failure Acute
17 (.8%)
Atrial Fibrillation
16 (.76%)
Show More Show More
Haematuria
16 (.76%)
Rectal Haemorrhage
16 (.76%)
Condition Aggravated
15 (.71%)
Pyrexia
15 (.71%)
Confusional State
14 (.66%)
Dyspnoea
14 (.66%)
Muscle Haemorrhage
14 (.66%)
Prothrombin Level Decreased
14 (.66%)
Prothrombin Time Prolonged
13 (.61%)
Cerebral Haemorrhage
12 (.57%)
Cytolytic Hepatitis
12 (.57%)
General Physical Health Deteriorati...
12 (.57%)
Inflammation
12 (.57%)
Loss Of Consciousness
12 (.57%)
Gastrointestinal Haemorrhage
11 (.52%)
Hypotension
11 (.52%)
Toxic Skin Eruption
11 (.52%)
Vomiting
11 (.52%)
Cerebrovascular Accident
10 (.47%)
Coma
10 (.47%)
Malaise
10 (.47%)
Oedema Peripheral
10 (.47%)
Prothrombin Time Shortened
10 (.47%)
Pulmonary Embolism
10 (.47%)
Agitation
9 (.43%)
Cerebral Haematoma
9 (.43%)
Dehydration
9 (.43%)
Drug Rash With Eosinophilia And Sys...
9 (.43%)
International Normalised Ratio Decr...
9 (.43%)
Respiratory Distress
9 (.43%)
Rhabdomyolysis
9 (.43%)
Abdominal Pain
8 (.38%)
Alanine Aminotransferase Increased
8 (.38%)
Aspartate Aminotransferase Increase...
8 (.38%)
Asthenia
8 (.38%)
Back Pain
8 (.38%)
Diarrhoea
8 (.38%)
Lung Disorder
8 (.38%)
Phlebitis
8 (.38%)
Vascular Purpura
8 (.38%)
Agranulocytosis
7 (.33%)
Arrhythmia
7 (.33%)
Cardiac Failure
7 (.33%)
Disorientation
7 (.33%)
Eosinophilia
7 (.33%)
Haemoptysis
7 (.33%)
Hypoxia
7 (.33%)
Infection
7 (.33%)
Melaena
7 (.33%)
Subcutaneous Haematoma
7 (.33%)
Thrombocytopenia
7 (.33%)
Urinary Tract Infection
7 (.33%)
Activated Partial Thromboplastin Ti...
6 (.28%)
C-reactive Protein Increased
6 (.28%)
Epistaxis
6 (.28%)
Hypovolaemic Shock
6 (.28%)
Leukocytoclastic Vasculitis
6 (.28%)
Multi-organ Failure
6 (.28%)
Pleural Effusion
6 (.28%)
Prothrombin Time Ratio Decreased
6 (.28%)
Pruritus
6 (.28%)
Somnolence
6 (.28%)
White Blood Cell Count Increased
6 (.28%)
Blood Bilirubin Increased
5 (.24%)
Blood Lactate Dehydrogenase Increas...
5 (.24%)
Blood Thyroid Stimulating Hormone I...
5 (.24%)
Drug Effect Decreased
5 (.24%)
Electrocardiogram Qt Prolonged
5 (.24%)
Hepatitis Fulminant
5 (.24%)
Hyperkalaemia
5 (.24%)
Hyperthyroidism
5 (.24%)
Hyponatraemia
5 (.24%)
Interstitial Lung Disease
5 (.24%)
Normochromic Normocytic Anaemia
5 (.24%)
Oesophagitis
5 (.24%)
Off Label Use
5 (.24%)
Pallor
5 (.24%)
Pulmonary Fibrosis
5 (.24%)
Pulmonary Oedema
5 (.24%)
Purpura
5 (.24%)
Rash Maculo-papular
5 (.24%)
Respiratory Failure
5 (.24%)
Skin Ulcer
5 (.24%)
Urticaria
5 (.24%)
Abdominal Pain Upper
4 (.19%)
Acute Coronary Syndrome
4 (.19%)
Anorexia
4 (.19%)
Aphasia
4 (.19%)
Arthralgia
4 (.19%)
Blood Fibrinogen Increased
4 (.19%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Previscan Fluindione, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Previscan Fluindione is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Previscan Fluindione

What are the most common Previscan Fluindione adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Previscan Fluindione, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Previscan Fluindione is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Previscan Fluindione According to Those Reporting Adverse Events

Why are people taking Previscan Fluindione, according to those reporting adverse events to the FDA?

Atrial Fibrillation
58
Drug Use For Unknown Indication
38
Product Used For Unknown Indication
32
Pulmonary Embolism
22
Ill-defined Disorder
18
Arrhythmia
17
Show More Show More
Phlebitis
16
Atrial Flutter
13
Thrombosis Prophylaxis
11
Deep Vein Thrombosis
6
Embolism
6
Thrombophlebitis
4
Venous Thrombosis
3
Cardiac Fibrillation
3
Thrombosis
3
Aortic Valve Replacement
2
Superior Vena Cava Syndrome
2
Mitral Valve Replacement
2
Cardiovascular Event Prophylaxis
2
Essential Thrombocythaemia
2
Myocardial Ischaemia
2
Cerebrovascular Disorder
2
Prophylaxis
2
Cerebral Artery Occlusion
2
Ischaemic Stroke
1
Cardiac Valve Disease
1
Hip Arthroplasty
1
Renal Cell Carcinoma Stage Unspecif...
1
Hypertensive Cardiomyopathy
1
Cor Pulmonale Chronic
1
Cardiomyopathy
1
Cardiac Flutter
1
Pulmonary Arterial Hypertension
1
Embolism Arterial
1
Legionella Infection
1
Peripheral Ischaemia
1
Arrhythmia Supraventricular
1
Subendocardial Ischaemia
1
Cerebrovascular Accident
1
Hypertensive Heart Disease
1
Anticoagulant Therapy
1
Mitral Valve Disease
1
Arteriopathic Disease
1
Ischaemic Cardiomyopathy
1
Cardiac Failure
1
Cardiac Valve Replacement Complicat...
1
Myocardial Infarction
1
Cerebral Thrombosis
1
Cardiac Valve Prosthesis User
1
Disease Recurrence
1
Angina Pectoris
1

Previscan Fluindione Case Reports

What Previscan Fluindione safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Previscan Fluindione. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Previscan Fluindione.